JP2004525174A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525174A5
JP2004525174A5 JP2002579437A JP2002579437A JP2004525174A5 JP 2004525174 A5 JP2004525174 A5 JP 2004525174A5 JP 2002579437 A JP2002579437 A JP 2002579437A JP 2002579437 A JP2002579437 A JP 2002579437A JP 2004525174 A5 JP2004525174 A5 JP 2004525174A5
Authority
JP
Japan
Prior art keywords
optionally substituted
compound
formula
nhc
nhr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002579437A
Other languages
English (en)
Japanese (ja)
Other versions
JP4366079B2 (ja
JP2004525174A (ja
Filing date
Publication date
Priority claimed from GBGB0108876.4A external-priority patent/GB0108876D0/en
Application filed filed Critical
Publication of JP2004525174A publication Critical patent/JP2004525174A/ja
Publication of JP2004525174A5 publication Critical patent/JP2004525174A5/ja
Application granted granted Critical
Publication of JP4366079B2 publication Critical patent/JP4366079B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002579437A 2001-04-09 2002-04-08 ビピペリジニル誘導体およびケモカインレセプターインヒビターとしてのそれらの使用 Expired - Fee Related JP4366079B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108876.4A GB0108876D0 (en) 2001-04-09 2001-04-09 Organic Compounds
PCT/EP2002/003871 WO2002081449A1 (en) 2001-04-09 2002-04-08 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors

Publications (3)

Publication Number Publication Date
JP2004525174A JP2004525174A (ja) 2004-08-19
JP2004525174A5 true JP2004525174A5 (enExample) 2005-06-09
JP4366079B2 JP4366079B2 (ja) 2009-11-18

Family

ID=9912541

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002579437A Expired - Fee Related JP4366079B2 (ja) 2001-04-09 2002-04-08 ビピペリジニル誘導体およびケモカインレセプターインヒビターとしてのそれらの使用

Country Status (27)

Country Link
US (1) US20040142920A1 (enExample)
EP (1) EP1379504B1 (enExample)
JP (1) JP4366079B2 (enExample)
KR (1) KR100616039B1 (enExample)
CN (1) CN100469767C (enExample)
AR (1) AR035815A1 (enExample)
AT (1) ATE446950T1 (enExample)
AU (1) AU2002302511B2 (enExample)
BR (1) BR0208741A (enExample)
CA (1) CA2439241C (enExample)
CZ (1) CZ20032723A3 (enExample)
DE (1) DE60234167D1 (enExample)
EC (1) ECSP034765A (enExample)
ES (1) ES2335393T3 (enExample)
GB (1) GB0108876D0 (enExample)
HU (1) HUP0303724A3 (enExample)
IL (1) IL157428A0 (enExample)
MX (1) MXPA03009220A (enExample)
NO (1) NO20034324L (enExample)
NZ (1) NZ528712A (enExample)
PE (1) PE20021004A1 (enExample)
PL (1) PL363011A1 (enExample)
PT (1) PT1379504E (enExample)
RU (1) RU2296751C2 (enExample)
SK (1) SK12422003A3 (enExample)
WO (1) WO2002081449A1 (enExample)
ZA (1) ZA200306432B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7307090B2 (en) 2001-07-02 2007-12-11 Astrazeneca Ab Piperidine derivatives useful as modulators of chemokine receptor activity
GB0120461D0 (en) 2001-08-22 2001-10-17 Astrazeneca Ab Novel compounds
AR036366A1 (es) 2001-08-29 2004-09-01 Schering Corp Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit
GB0122503D0 (en) 2001-09-18 2001-11-07 Astrazeneca Ab Chemical compounds
SE0200844D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0200843D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0202838D0 (sv) * 2002-09-24 2002-09-24 Astrazeneca Ab Chemical compounds
MXPA05003290A (es) * 2002-10-04 2005-07-05 Ucb Sa Derivados de 4-aminopiperidina, procesos para su preparacion y su uso como medicamentos.
GB0223223D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
DE60324014D1 (de) * 2002-12-13 2008-11-20 Smithkline Beecham Corp Heterocyclische verbindungen alsccr5-antagonisten
SE0300957D0 (sv) 2003-04-01 2003-04-01 Astrazeneca Ab Chemical compounds
JPWO2004092136A1 (ja) * 2003-04-18 2006-07-06 小野薬品工業株式会社 含窒素複素環化合物およびその用途
FR2854158B1 (fr) * 2003-04-25 2006-11-17 Sanofi Synthelabo Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique
BRPI0411414A (pt) * 2003-06-13 2006-07-25 Schering Ag derivados de quinolil amida como antagonistas de cdr-5
JP4757802B2 (ja) * 2003-11-03 2011-08-24 シェーリング コーポレイション ケモカインレセプターの阻害剤として有用なビピペリジニル誘導体
US7498346B2 (en) * 2003-12-11 2009-03-03 Genzyme Corporation Chemokine receptor binding compounds
US7381738B2 (en) 2004-02-19 2008-06-03 Bristol-Myers Squibb Company Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7479496B2 (en) 2004-02-19 2009-01-20 Bristol-Myers Squibb Company Substituted spiro azabicyclics as modulators of chemokine receptor activity
US7288563B2 (en) 2004-02-19 2007-10-30 Bristol-Myers Squibb Company Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7230022B2 (en) 2004-02-19 2007-06-12 Bristol-Myers Squibb Company Substituted fused bicyclic amines as modulators of chemokine receptor activity
EP1844037A1 (en) * 2005-01-20 2007-10-17 Pfizer Limited Chemical compounds
EP2402316A1 (en) 2005-07-21 2012-01-04 AstraZeneca AB (Publ) Piperidine derivatives
US20080108586A1 (en) * 2006-09-06 2008-05-08 Incyte Corporation Combination therapy for human immunodeficiency virus infection
EP2088860A4 (en) * 2006-12-06 2010-12-22 Genzyme Corp COMPOUNDS FOR BINDING TO A CHEMOKINE RECEPTOR
AU2010232729A1 (en) 2009-03-31 2011-10-20 Arqule, Inc. Substituted indolo-pyridinone compounds
CA2829219C (en) 2011-03-09 2021-03-16 Richard G. Pestell Prostate cancer cell lines, gene signatures and uses thereof
US9453836B2 (en) * 2012-05-14 2016-09-27 Richard G. Pestell Use of modulators of CCR5 in the treatment of cancer and cancer metastasis
WO2015091414A2 (de) 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituierte piperidinyl-tetrahydrochinoline
JP2017501164A (ja) 2013-12-19 2017-01-12 バイエル ファーマ アクチエンゲゼルシャフト 置換されたピペリジニルテトラヒドロキノリン類
WO2015091420A1 (de) 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituierte bipiperidinyl-derivate als adrenrezeptor alpha 2c antagonisten
WO2015091415A1 (de) 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituierte bipiperidinyl-derivate als adrenorezeptor alpha 2c antagonisten

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
TW531537B (en) * 1995-12-27 2003-05-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
US5952349A (en) * 1996-07-10 1999-09-14 Schering Corporation Muscarinic antagonists for treating memory loss
BR9712023A (pt) * 1996-09-10 1999-08-31 Thomae Gmbh Dr K Aminoácidos derivados, medicamentos contendo esses compostos e processos para a sua preparação.
DE19637043A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel und Reagenzien
DE19643331A1 (de) * 1996-10-21 1998-04-23 Thomae Gmbh Dr K 1-(4-Piperidinyl)-piperidinylene, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
EP1175402B1 (en) * 1999-05-04 2005-07-20 Schering Corporation Piperidine derivatives useful as ccr5 antagonists
US6391865B1 (en) * 1999-05-04 2002-05-21 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
EP1192133B1 (en) * 1999-06-11 2006-11-02 Merck & Co., Inc. N-cyclopentyl modulators of chemokine receptor activity
EP1296949A2 (en) * 2000-06-21 2003-04-02 Bristol-Myers Squibb Pharma Company Piperidine amides as modulators of chemokine receptor activity
JP2004509108A (ja) * 2000-09-14 2004-03-25 シェーリング コーポレイション 置換尿素神経ペプチドyy5受容体アンタゴニスト
AR036366A1 (es) * 2001-08-29 2004-09-01 Schering Corp Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit
GB0223223D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2004525174A5 (enExample)
RU2003130642A (ru) Бипиперидинильные производные и их применение в качестве ингибиторов хемокиновых рецепторов
RU2309951C2 (ru) Производные никотинамида, способы их получения, фармацевтическая композиция на их основе и применение
JP2005505618A5 (enExample)
JP2005511531A5 (enExample)
JP2005509622A5 (enExample)
JP2021501756A5 (enExample)
JP2009504763A5 (enExample)
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
JP2003500404A5 (enExample)
JP2011530500A5 (enExample)
RU2009105826A (ru) 2,4-ди(ариламино)питимидин-5-карбоксамидные соединения в качестве ингибиторов jak-киназ
JP2005511532A5 (enExample)
MX2010008101A (es) Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un silanilo, su preparacion y su aplicacion en terapeutica.
JP2005519932A5 (enExample)
JP2010511626A5 (enExample)
SI3106463T1 (en) Compounds of substituted pyrazolo (1,5-) pyrimidine as inhibitors of TRK kinase
JP2015522650A5 (enExample)
JP2005511698A5 (enExample)
GB0128499D0 (en) Therapeutic agents
RU2011105810A (ru) Азотсодержащие бициклические гетероциклические соединения
YU73502A (sh) Farmaceutski aktivni derivati pirolidina
JP2012513390A5 (enExample)
JP2004523478A5 (enExample)
JP2009520695A5 (enExample)